-
1
-
-
0021814903
-
Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2′-nor-2′-deoxyguanosine
-
Ashton, W. T., L. F. Canning, G. F. Reynolds, R. L. Tolman, J. D. Karkas, R. Liou, M. E. Davies, C. M. DeWitt, H. C. Perry, and A. K. Field. 1985. Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2′-nor-2′-deoxyguanosine. J. Med. Chem. 28:925-933.
-
(1985)
J. Med. Chem.
, vol.28
, pp. 925-933
-
-
Ashton, W.T.1
Canning, L.F.2
Reynolds, G.F.3
Tolman, R.L.4
Karkas, J.D.5
Liou, R.6
Davies, M.E.7
Dewitt, C.M.8
Perry, H.C.9
Field, A.K.10
-
2
-
-
0024262556
-
Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl] methyl]guanine and related compounds
-
Ashton, W. T., L. C. Meurer, C. L. Cantone, A. K. Field, J. Hannah, J. D. Karkas, R. Liou, G. F. Patel, H. C. Perry, and A. F. Wagner. 1988. Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl] methyl]guanine and related compounds. J. Med. Chem. 31:2304-2315.
-
(1988)
J. Med. Chem.
, vol.31
, pp. 2304-2315
-
-
Ashton, W.T.1
Meurer, L.C.2
Cantone, C.L.3
Field, A.K.4
Hannah, J.5
Karkas, J.D.6
Liou, R.7
Patel, G.F.8
Perry, H.C.9
Wagner, A.F.10
-
3
-
-
0028329454
-
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type I in vitro
-
Baba, M., S. Shigeta, S. Yuasa, H. Takashima, K. Sekiya, M. Ubasawa, H. Tanaka, T. Miyasaka, R. T. Walker, and E. De Clercq. 1994. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type I in vitro. Antimicrob. Agents Chemother. 38:688-692.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 688-692
-
-
Baba, M.1
Shigeta, S.2
Yuasa, S.3
Takashima, H.4
Sekiya, K.5
Ubasawa, M.6
Tanaka, H.7
Miyasaka, T.8
Walker, R.T.9
De Clercq, E.10
-
4
-
-
0029946597
-
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives
-
Balzarini, J., A. Karlsson, S. Aquaro, C. F. Perno, D. Cahard, L. Naesens, E. De Clercq, and C. McGuigan. 1996. Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proc. Natl. Acad. Sci. USA 93:7295-7299.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 7295-7299
-
-
Balzarini, J.1
Karlsson, A.2
Aquaro, S.3
Perno, C.F.4
Cahard, D.5
Naesens, L.6
De Clercq, E.7
McGuigan, C.8
-
6
-
-
0032485470
-
9-Hydroxymethyl-cyclopropylidenemethylenyladenine: The design, facile synthesis, isomer separation and anti-HIV-1 activities
-
Cheng, C., T. Shimo, K. Somekawa, and M. Baba. 1998. 9-Hydroxymethyl-cyclopropylidenemethylenyladenine: the design, facile synthesis, isomer separation and anti-HIV-1 activities. Tetrahedron 54:2031-2040.
-
(1998)
Tetrahedron
, vol.54
, pp. 2031-2040
-
-
Cheng, C.1
Shimo, T.2
Somekawa, K.3
Baba, M.4
-
7
-
-
0023052240
-
Isolation of a new human retrovirus from West African patients with AIDS
-
Clavel, F., D. Guetard, F. Brun-Vezinet, S. Chamaret, M. A. Key, M. O. Santos-Ferreira, A. G. Laurent, C. Dauguet, C. Katlama, C. Rouzious, D. Klatzmann, J. L. Champalimaud, and L. Montagnier. 1986. Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343-346.
-
(1986)
Science
, vol.233
, pp. 343-346
-
-
Clavel, F.1
Guetard, D.2
Brun-Vezinet, F.3
Chamaret, S.4
Key, M.A.5
Santos-Ferreira, M.O.6
Laurent, A.G.7
Dauguet, C.8
Katlama, C.9
Rouzious, C.10
Klatzmann, D.11
Champalimaud, J.L.12
Montagnier, L.13
-
8
-
-
0030982931
-
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
-
Daluge, S. M., S. S. Good, M. B. Faletto, W. H. Miller, M. H. St. Clair, L. R. Boone, M. Tisdale, N. R. Parry, J. E. Reardon, R. E. Dornsife, D. R. Averett, and T. A. Krenitsky. 1997. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob. Agents Chemother. 41:1082-1093.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1082-1093
-
-
Daluge, S.M.1
Good, S.S.2
Faletto, M.B.3
Miller, W.H.4
St. Clair, M.H.5
Boone, L.R.6
Tisdale, M.7
Parry, N.R.8
Reardon, J.E.9
Dornsife, R.E.10
Averett, D.R.11
Krenitsky, T.A.12
-
9
-
-
0028120730
-
HIV resistance to reverse transcriptase inhibitors
-
De Clercq, E. 1994. HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol. 47:155-169.
-
(1994)
Biochem. Pharmacol.
, vol.47
, pp. 155-169
-
-
De Clercq, E.1
-
10
-
-
0030708683
-
In search of a selective antiviral chemotherapy
-
De Clercq, E. 1997. In search of a selective antiviral chemotherapy. Clin. Microbiol. Rev. 10:674-693.
-
(1997)
Clin. Microbiol. Rev.
, vol.10
, pp. 674-693
-
-
De Clercq, E.1
-
11
-
-
0030722272
-
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: A randomized, double-blind, placebo-controlled trial
-
Decks, S. G., A. Collier, J. Lalezari, A. Pavia, D. Rodrigue, W. L. Drew, J. Toole, H. S. Jaffe, A. S. Mulato, P. D. Lamy, W. Li, J. M. Cherrington, N. Hellmann, and J. Kahn. 1997. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J. Infect. Dis. 176:1517-1523.
-
(1997)
J. Infect. Dis.
, vol.176
, pp. 1517-1523
-
-
Decks, S.G.1
Collier, A.2
Lalezari, J.3
Pavia, A.4
Rodrigue, D.5
Drew, W.L.6
Toole, J.7
Jaffe, H.S.8
Mulato, A.S.9
Lamy, P.D.10
Li, W.11
Cherrington, J.M.12
Hellmann, N.13
Kahn, J.14
-
12
-
-
0007621056
-
Adenallene and cytallene: Acyclic nucleosides that inhibit replication and cytopathic effect of human immunodeficiency virus (HIV) in vitro
-
Hayashi, S., S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, and S. Broder. 1988. Adenallene and cytallene: acyclic nucleosides that inhibit replication and cytopathic effect of human immunodeficiency virus (HIV) in vitro. Proc. Natl. Acad. Sci. USA 85:6127-6131.
-
(1988)
Proc. Natl. Acad. Sci. USA
, vol.85
, pp. 6127-6131
-
-
Hayashi, S.1
Phadtare, S.2
Zemlicka, J.3
Matsukura, M.4
Mitsuya, H.5
Broder, S.6
-
13
-
-
0030199967
-
Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method
-
Kodama, E., S. Shigeta, T. Suzuki, and E. De Clercq. 1996. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Antivir. Res. 31:159-164.
-
(1996)
Antivir. Res.
, vol.31
, pp. 159-164
-
-
Kodama, E.1
Shigeta, S.2
Suzuki, T.3
De Clercq, E.4
-
14
-
-
0025218997
-
Acid-stable 2′-β-fluoro purine dideoxynucleosides as active agents against HIV
-
Marquez, V. E., C. K.-H. Tseng, H. Mitsuya, S. Aoki, J. A. Kelley, H. J. Ford, J. S. Roth, S. Broder, D. G. Johns, and J. S. Driscoll. 1990. Acid-stable 2′-β-fluoro purine dideoxynucleosides as active agents against HIV. J. Med. Chem. 33:978-985.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 978-985
-
-
Marquez, V.E.1
Tseng, C.K.-H.2
Mitsuya, H.3
Aoki, S.4
Kelley, J.A.5
Ford, H.J.6
Roth, J.S.7
Broder, S.8
Johns, D.G.9
Driscoll, J.S.10
-
15
-
-
0345002794
-
Nucleoside analogues and their antiretroviral activity
-
H. Mitsuya (ed.), R. G. Langes Company, Austin, Tex
-
Mitsuya, H. 1997. Nucleoside analogues and their antiretroviral activity, p. 3-22. In H. Mitsuya (ed.), Anti-HIV nucleosides: past, present and future. R. G. Langes Company, Austin, Tex.
-
(1997)
Anti-HIV Nucleosides: Past, Present and Future
, pp. 3-22
-
-
Mitsuya, H.1
-
16
-
-
0002052695
-
Discovery and development of antiretroviral therapeutics for HIV infection
-
T. C. Merigan (ed.), Williams & Wilkins, Baltimore, Md
-
Mitsuya, H., and J. Erickson. 1998. Discovery and development of antiretroviral therapeutics for HIV infection, p. 751-780. In T. C. Merigan (ed.), Textbook of AIDS medicine, Williams & Wilkins, Baltimore, Md.
-
(1998)
Textbook of AIDS Medicine
, pp. 751-780
-
-
Mitsuya, H.1
Erickson, J.2
-
18
-
-
0023687234
-
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
-
Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De Clercq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
-
(1988)
J. Virol. Methods
, vol.20
, pp. 309-321
-
-
Pauwels, R.1
Balzarini, J.2
Baba, M.3
Snoeck, R.4
Schols, D.5
Herdewijn, P.6
Desmyter, J.7
De Clercq, E.8
-
19
-
-
15444353199
-
(Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity
-
Qiu, Y. L., M. B. Ksebati, R. G. Ptak, B. Y. Fan, J. M. Breitenbach, J.-S. Lin, Y. C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J. Med. Chem. 41:10-23.
-
(1998)
J. Med. Chem.
, vol.41
, pp. 10-23
-
-
Qiu, Y.L.1
Ksebati, M.B.2
Ptak, R.G.3
Fan, B.Y.4
Breitenbach, J.M.5
Lin, J.-S.6
Cheng, Y.C.7
Kern, E.R.8
Drach, J.C.9
Zemlicka, J.10
-
20
-
-
0031849741
-
(Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methylpurines and pyrimidines as antiviral agents
-
Qiu, Y. L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-[(hydroxymethyl)cyclopropylidene]methylpurines and pyrimidines as antiviral agents. Antivir. Chem. Chemother. 9:341-352.
-
(1998)
Antivir. Chem. Chemother.
, vol.9
, pp. 341-352
-
-
Qiu, Y.L.1
Ptak, R.G.2
Breitenbach, J.M.3
Lin, J.-S.4
Cheng, Y.-C.5
Kern, E.R.6
Drach, J.C.7
Zemlicka, J.8
-
21
-
-
0032802987
-
Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides
-
in press
-
Qiu, Y.-L., R. G. Ptak, J. M. Breitenbach, J.-S. Lin, Y.-C. Cheng, J. C. Drach, E. R. Kern, and J. Zemlicka. Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides. Antivir. Res., in press.
-
Antivir. Res.
-
-
Qiu, Y.-L.1
Ptak, R.G.2
Breitenbach, J.M.3
Lin, J.-S.4
Cheng, Y.-C.5
Drach, J.C.6
Kern, E.R.7
Zemlicka, J.8
-
22
-
-
0011129306
-
In vitro evaluation of experimental agents for anti-HIV activity
-
J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, John Wiley & Sons, Inc., New York, N.Y.
-
Richman, D. D., V. A. Johnson, D. L. Mayers, T. Shirasaka, M. C. O'Brien, and H. Mitsuya. 1993. In vitro evaluation of experimental agents for anti-HIV activity, p. 12.9.1-12.9.21. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
-
(1993)
Current Protocols in Immunology
, pp. 1291-12921
-
-
Richman, D.D.1
Johnson, V.A.2
Mayers, D.L.3
Shirasaka, T.4
O'Brien, M.C.5
Mitsuya, H.6
-
23
-
-
0028823560
-
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells
-
Shirasaka, T., S. Chokekijchai, A. Yamada, G. Gosselin, J.-L. Imbach, and H. Mitsuya. 1995. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 39: 2555-2559.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 2555-2559
-
-
Shirasaka, T.1
Chokekijchai, S.2
Yamada, A.3
Gosselin, G.4
Imbach, J.-L.5
Mitsuya, H.6
-
24
-
-
0028940084
-
Emergence of human immunodeficiency virus type-1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
-
Shirasaka, T., M. F. Kavlick, T. Ueno, W.-Y. Gao, E. Kojima, M. L. Alcaide, S. Chokekijchai, B. M. Roy, E. Arnold, R. Yarchuan, and H. Mitsuya. 1995. Emergence of human immunodeficiency virus type-1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92:2398-2402.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 2398-2402
-
-
Shirasaka, T.1
Kavlick, M.F.2
Ueno, T.3
Gao, W.-Y.4
Kojima, E.5
Alcaide, M.L.6
Chokekijchai, S.7
Roy, B.M.8
Arnold, E.9
Yarchuan, R.10
Mitsuya, H.11
-
25
-
-
0027398296
-
Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: An in vitro comparative study
-
Shirasaka, T., R. Yarchoan, M. C. O'Brien, R. N. Husson, B. D. Anderson, E. Kojima, T. Shimada, S. Broder, and H. Mitsuya. 1993. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study. Proc. Natl. Acad. Sci. USA 90:562-566.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 562-566
-
-
Shirasaka, T.1
Yarchoan, R.2
O'Brien, M.C.3
Husson, R.N.4
Anderson, B.D.5
Kojima, E.6
Shimada, T.7
Broder, S.8
Mitsuya, H.9
-
26
-
-
0025770237
-
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: Synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
-
Tanaka, H., M. Baba, S. Saito, T. Miyasaka, H. Takasha, K. Sekiya, M. Ubasawa, I. Nitta, R. T. Walker, H. Nakashima, and E. De Clercq. 1991. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J. Med. Chem. 34:1508-1511.
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1508-1511
-
-
Tanaka, H.1
Baba, M.2
Saito, S.3
Miyasaka, T.4
Takasha, H.5
Sekiya, K.6
Ubasawa, M.7
Nitta, I.8
Walker, R.T.9
Nakashima, H.10
De Clercq, E.11
-
27
-
-
0031009294
-
In vitro induction of human immunodeficiency virus type 1 (HIV-1) variants resistant to 2′-β-fluoro-2′,3′-dideoxyadenosine (F-ddA)
-
Tanaka, M., R. V. Srinivas, T. Ueno, M. F. Kavlick, F. K. Hui, A. Fridland, J. S. Driscoll, and H. Mitsuya. 1997. In vitro induction of human immunodeficiency virus type 1 (HIV-1) variants resistant to 2′-β-fluoro-2′,3′-dideoxyadenosine (F-ddA). Antimicrob. Agents Chemother. 41:1313-1318.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1313-1318
-
-
Tanaka, M.1
Srinivas, R.V.2
Ueno, T.3
Kavlick, M.F.4
Hui, F.K.5
Fridland, A.6
Driscoll, J.S.7
Mitsuya, H.8
|